Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis.
Berkers G, van Mourik P, Vonk AM, Kruisselbrink E, Dekkers JF, de Winter-de Groot KM, Arets HGM, Marck-van der Wilt REP, Dijkema JS, Vanderschuren MM, Houwen RHJ, Heijerman HGM, van de Graaf EA, Elias SG, Majoor CJ, Koppelman GH, Roukema J, Bakker M, Janssens HM, van der Meer R, Vries RGJ, Clevers HC, de Jonge HR, Beekman JM, van der Ent CK. Berkers G, et al. Among authors: heijerman hgm. Cell Rep. 2019 Feb 12;26(7):1701-1708.e3. doi: 10.1016/j.celrep.2019.01.068. Cell Rep. 2019. PMID: 30759382 Free article.
Gallbladder disease in cystic fibrosis.
Jebbink MC, Heijerman HG, Masclee AA, Lamers CB. Jebbink MC, et al. Neth J Med. 1992 Oct;41(3-4):123-6. Neth J Med. 1992. PMID: 1470281 Review.
[Hepatobiliary disorders in cystic fibrosis].
van de Meeberg PC, Bijleveld CM, Heijerman HG, Houwen RH, Sinaasappel M, van Berge Henegouwen GP. van de Meeberg PC, et al. Ned Tijdschr Geneeskd. 1994 Jul 2;138(27):1357-60. Ned Tijdschr Geneeskd. 1994. PMID: 8035893 Dutch. No abstract available.
Clinical trials in cystic fibrosis.
Döring G, Elborn JS, Johannesson M, de Jonge H, Griese M, Smyth A, Heijerman H; Consensus Study Group. Döring G, et al. J Cyst Fibros. 2007 Apr;6(2):85-99. doi: 10.1016/j.jcf.2007.02.001. J Cyst Fibros. 2007. PMID: 17350898 Free article. Review.
The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients.
van Mansfeld R, de Vrankrijker A, Brimicombe R, Heijerman H, Teding van Berkhout F, Spitoni C, Grave S, van der Ent C, Wolfs T, Willems R, Bonten M. van Mansfeld R, et al. PLoS One. 2016 Jun 9;11(6):e0157189. doi: 10.1371/journal.pone.0157189. eCollection 2016. PLoS One. 2016. PMID: 27280467 Free PMC article. Clinical Trial.
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.
Dekkers JF, Berkers G, Kruisselbrink E, Vonk A, de Jonge HR, Janssens HM, Bronsveld I, van de Graaf EA, Nieuwenhuis EE, Houwen RH, Vleggaar FP, Escher JC, de Rijke YB, Majoor CJ, Heijerman HG, de Winter-de Groot KM, Clevers H, van der Ent CK, Beekman JM. Dekkers JF, et al. Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278. Sci Transl Med. 2016. PMID: 27334259
β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis.
Vijftigschild LA, Berkers G, Dekkers JF, Zomer-van Ommen DD, Matthes E, Kruisselbrink E, Vonk A, Hensen CE, Heida-Michel S, Geerdink M, Janssens HM, van de Graaf EA, Bronsveld I, de Winter-de Groot KM, Majoor CJ, Heijerman HG, de Jonge HR, Hanrahan JW, van der Ent CK, Beekman JM. Vijftigschild LA, et al. Eur Respir J. 2016 Sep;48(3):768-79. doi: 10.1183/13993003.01661-2015. Epub 2016 Jul 28. Eur Respir J. 2016. PMID: 27471203 Free article. Clinical Trial.
Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study.
van Velzen AJ, Uges JWF, Heijerman HGM, Arets BGM, Nuijsink M, van der Wiel-Kooij EC, van Maarseveen EM, van Zanten GA, Pullens B, Touw DJ, Janssens HM. van Velzen AJ, et al. Among authors: heijerman hgm. Br J Clin Pharmacol. 2019 Sep;85(9):1984-1993. doi: 10.1111/bcp.13988. Epub 2019 Jul 10. Br J Clin Pharmacol. 2019. PMID: 31112621 Free PMC article. Clinical Trial.
Prevention of drug-related complications in cystic fibrosis.
van der Meer R, Touw DJ, Heijerman HGM. van der Meer R, et al. Among authors: heijerman hgm. Curr Opin Pulm Med. 2019 Nov;25(6):666-673. doi: 10.1097/MCP.0000000000000625. Curr Opin Pulm Med. 2019. PMID: 31503211 Review.
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS; VX17-445-103 Trial Group. Heijerman HGM, et al. Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31. Lancet. 2019. PMID: 31679946 Free PMC article. Clinical Trial.
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R; VX17-445-102 Study Group. Middleton PG, et al. N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31. N Engl J Med. 2019. PMID: 31697873 Free PMC article. Clinical Trial.
Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations.
de Winter-de Groot KM, Berkers G, Marck-van der Wilt REP, van der Meer R, Vonk A, Dekkers JF, Geerdink M, Michel S, Kruisselbrink E, Vries R, Clevers H, Vleggaar FP, Elias SG, Heijerman HGM, van der Ent CK, Beekman JM. de Winter-de Groot KM, et al. Among authors: heijerman hgm. J Cyst Fibros. 2020 Jul;19(4):614-619. doi: 10.1016/j.jcf.2019.10.022. Epub 2019 Nov 15. J Cyst Fibros. 2020. PMID: 31735562 Free article.
Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline.
Aalbers BL, de Winter-de Groot KM, Arets HGM, Hofland RW, de Kiviet AC, van Oirschot-van de Ven MMM, Kruijswijk MA, Schotman S, Michel S, van der Ent CK, Heijerman HGM. Aalbers BL, et al. Among authors: heijerman hgm. J Cyst Fibros. 2020 Jul;19(4):654-658. doi: 10.1016/j.jcf.2019.12.015. Epub 2020 Jan 7. J Cyst Fibros. 2020. PMID: 31924546 Free article.
Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement.
Hollander-Kraaijeveld FM, van Lanen AS, de Roos NM, van de Graaf EA, Heijerman HGM. Hollander-Kraaijeveld FM, et al. Among authors: heijerman hgm. J Cyst Fibros. 2020 Nov;19(6):975-980. doi: 10.1016/j.jcf.2020.03.013. Epub 2020 Apr 11. J Cyst Fibros. 2020. PMID: 32291160 Free article. No abstract available.
Females with cystic fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males.
Aalbers BL, Hofland RW, Bronsveld I, de Winter-de Groot KM, Arets HGM, de Kiviet AC, van Oirschot-van de Ven MMM, Kruijswijk MA, Schotman S, Michel S, van der Ent CK, Heijerman HGM. Aalbers BL, et al. Among authors: heijerman hgm. J Cyst Fibros. 2021 Jan;20(1):e7-e11. doi: 10.1016/j.jcf.2020.05.004. Epub 2020 May 21. J Cyst Fibros. 2021. PMID: 32448708 Free article.
Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation.
Berkers G, van der Meer R, van Mourik P, Vonk AM, Kruisselbrink E, Suen SW, Heijerman HG, Majoor CJ, Koppelman GH, Roukema J, Janssens HM, de Rijke YB, Kemper EM, Beekman JM, van der Ent CK, de Jonge HR. Berkers G, et al. J Cyst Fibros. 2020 Nov;19(6):955-961. doi: 10.1016/j.jcf.2020.04.014. Epub 2020 Jun 1. J Cyst Fibros. 2020. PMID: 32499204 Free article. Clinical Trial.
Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation.
Berkers G, van der Meer R, Heijerman H, Beekman JM, Boj SF, Vries RGJ, van Mourik P, Doyle JR, Audhya P, Yuan ZJ, Kinnman N, van der Ent CK. Berkers G, et al. J Cyst Fibros. 2021 Sep;20(5):761-767. doi: 10.1016/j.jcf.2020.11.007. Epub 2020 Nov 26. J Cyst Fibros. 2021. PMID: 33249003 Free article. Clinical Trial.
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
Kos R, Brinkman P, Neerincx AH, Paff T, Gerritsen MG, Lammers A, Kraneveld AD, Heijerman HGM, Janssens HM, Davies JC, Majoor CJ, Weersink EJ, Sterk PJ, Haarman EG, Bos LD, Maitland-van der Zee AH; Amsterdam Mucociliary Clearance Disease (AMCD) Research Group and the Amsterdam UMC Breath Research Group. Kos R, et al. Among authors: heijerman hgm. J Cyst Fibros. 2022 Jan;21(1):e28-e34. doi: 10.1016/j.jcf.2021.04.015. Epub 2021 May 18. J Cyst Fibros. 2022. PMID: 34016557 Free article. Review.
CFTR Modulators: Does One Dose Fit All?
van der Meer R, Wilms EB, Heijerman HGM. van der Meer R, et al. Among authors: heijerman hgm. J Pers Med. 2021 May 24;11(6):458. doi: 10.3390/jpm11060458. J Pers Med. 2021. PMID: 34073663 Free PMC article. Review.
Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia.
Amatngalim GD, Rodenburg LW, Aalbers BL, Raeven HH, Aarts EM, Sarhane D, Spelier S, Lefferts JW, Silva IA, Nijenhuis W, Vrendenbarg S, Kruisselbrink E, Brunsveld JE, van Drunen CM, Michel S, de Winter-de Groot KM, Heijerman HG, Kapitein LC, Amaral MD, van der Ent CK, Beekman JM. Amatngalim GD, et al. Life Sci Alliance. 2022 Aug 3;5(12):e202101320. doi: 10.26508/lsa.202101320. Life Sci Alliance. 2022. PMID: 35922154 Free PMC article.
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.
Semenchuk J, Naito Y, Charman SC, Carr SB, Cheng SY, Marshall BC, Faro A, Elbert A, Gutierrez HH, Goss CH, Karadag B, Burgel PR, Colombo C, Salvatore M, Padoan R, Daneau G, Harutyunyan S, Kashirskaya N, Kirwan L, Middleton PG, Ruseckaite R, de Monestrol I, Naehrlich L, Mondejar-Lopez P, Jung A, van Rens J, Bakkeheim E, Orenti A, Zomer-van Ommen D, da Silva-Filho LVR, Fernandes FF, Zampoli M, Stephenson AL; Global CF Registry Collaboration. Semenchuk J, et al. J Cyst Fibros. 2024 Sep;23(5):815-822. doi: 10.1016/j.jcf.2024.07.019. Epub 2024 Aug 26. J Cyst Fibros. 2024. PMID: 39191560 Free article.
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study.
KOALA study group; van Gemert JP, Luijk B, Hellemons ME, Visser KA, Hansen CME, van der Meer R, Gan CT, van der Vaart H, Akkerman OW, Steenhuis WN, Verkleij M, Heijerman HGM, Verschuuren EAM. KOALA study group, et al. Among authors: heijerman hgm. JHLT Open. 2025 Jan 17;7:100210. doi: 10.1016/j.jhlto.2025.100210. eCollection 2025 Feb. JHLT Open. 2025. PMID: 40144832 Free PMC article.
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.
Semenchuk J, Naito Y, Charman SC, Carr SB, Duckers J, Cheng SY, Marshall BC, Faro A, Elbert A, Goss CH, Burgel PR, Colombo C, Salvatore M, Kashirskaya N, Kirwan L, Middleton PG, Naehrlich L, Pastor-Vivero MD, Jung A, Bakkeheim E, Zolin A, Orenti A, Zomer-van Ommen DD, Zampoli M, Stephenson AL; Global CF Registry Collaboration. Semenchuk J, et al. J Cyst Fibros. 2026 Mar 11:S1569-1993(26)00038-X. doi: 10.1016/j.jcf.2026.02.009. Online ahead of print. J Cyst Fibros. 2026. PMID: 41820127
A cystic fibrosis mutation associated with mild lung disease.
Gan KH, Veeze HJ, van den Ouweland AM, Halley DJ, Scheffer H, van der Hout A, Overbeek SE, de Jongste JC, Bakker W, Heijerman HG. Gan KH, et al. N Engl J Med. 1995 Jul 13;333(2):95-9. doi: 10.1056/NEJM199507133330204. N Engl J Med. 1995. PMID: 7539891 Free article.
Present and future aspects of cystic fibrosis.
Heijerman HG, van der Laag J, de Jongste JC, Bakker W. Heijerman HG, et al. Neth J Med. 1995 Jun;46(6):263-5. doi: 10.1016/0300-2977(94)00016-3. Neth J Med. 1995. PMID: 7643939 No abstract available.
Inhalation of antibiotics in cystic fibrosis.
Touw DJ, Brimicombe RW, Hodson ME, Heijerman HG, Bakker W. Touw DJ, et al. Eur Respir J. 1995 Sep;8(9):1594-604. Eur Respir J. 1995. PMID: 8575589 Free article. Review.
Nutrition in patients with cystic fibrosis: a European Consensus.
Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, Robberecht E, Döring G. Sinaasappel M, et al. J Cyst Fibros. 2002 Jun;1(2):51-75. doi: 10.1016/s1569-1993(02)00032-2. J Cyst Fibros. 2002. PMID: 15463811 Free article. Review.
Demographics of glucose metabolism in cystic fibrosis.
van den Berg JM, Kouwenberg JM, Heijerman HG. van den Berg JM, et al. J Cyst Fibros. 2009 Jul;8(4):276-9. doi: 10.1016/j.jcf.2009.04.010. Epub 2009 May 24. J Cyst Fibros. 2009. PMID: 19467621 Free article.
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre.
Conway S, Balfour-Lynn IM, De Rijcke K, Drevinek P, Foweraker J, Havermans T, Heijerman H, Lannefors L, Lindblad A, Macek M, Madge S, Moran M, Morrison L, Morton A, Noordhoek J, Sands D, Vertommen A, Peckham D. Conway S, et al. J Cyst Fibros. 2014 May;13 Suppl 1:S3-22. doi: 10.1016/j.jcf.2014.03.009. J Cyst Fibros. 2014. PMID: 24856776 Free PMC article. Review.
153 results